Last updated on December 2018

A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane


Brief description of study

This is a Phase IV, single-arm, multicenter, open-label clinical trial designed to assess the safety of trastuzumab emtansine in Indian patients with HER2-positive unresectable locally advanced breast cancer (LABC) or metastatic breast cancer (mBC) who have received prior treatment with trastuzumab and a taxane.

Clinical Study Identifier: NCT02658734

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: ML29662 ...

Indraprastha Apollo Hospitals
New Delhi, India
  Connect »

Reference Study ID Number: ML29662 ...

Rajiv Gandhi Cancer Inst.&Research Center; Medical Oncology
New Delhi, India
  Connect »

Reference Study ID Number: ML29662 ...

Apollo Hospitals International Limited
Gandhinagar, India
  Connect »

Reference Study ID Number: ML29662 ...

Manipal Hospital; Department of Oncology
Bangalore, India
  Connect »

Reference Study ID Number: ML29662 ...

Tata Memorial Hospital; Dept of Medical Oncology
Mumbai, India
  Connect »

Reference Study ID Number: ML29662 ...

Christian Medical College & Hospital; Medicine
Vellore, India
  Connect »

Reference Study ID Number: ML29662 ...

Healthcare Global Enterprises Limited
Bangalore, India
  Connect »

Reference Study ID Number: ML29662 ...

Vikram Hospital Bengaluru Private Limited
Bengaluru, India
  Connect »

Reference Study ID Number: ML29662 ...

Artemis Health Institute
Gurgaon, India
  Connect »

Reference Study ID Number: ML29662 ...

Fortis Memorial Research Institute; Department of Medical Oncology & Haematology
Gurgaon, India
  Connect »

Reference Study ID Number: ML29662 ...

Sir Gangaram Hospital; Medical Oncology
New Delhi, India
  Connect »

Reference Study ID Number: ML29662 ...

Dr. B L Kapur Memorial Hospital; BLK Cancer Centre
New Delhi, India
  Connect »

Reference Study ID Number: ML29662 ...

Max Super Speciality Hospital
New Delhi, India
  Connect »

Reference Study ID Number: ML29662 ...

Max Super Speciality Hospital; Medical Oncology
North WEST Delhi, India
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.